Hereditary breast and ovarian cancer: from genes to molecular targeted therapies.
Ponti G, De Angelis C, Ponti R, Pongetti L, Losi L, Sticchi A, Tomasi A, Ozben T.
Crit Rev Clin Lab Sci. 2023 Dec;60(8):640-650. doi: 10.1080/10408363.2023.2234488. Epub 2023 Jul 16.
Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline.
Sessa C, Balmaña J, Bober SL, Cardoso MJ, Colombo N, Curigliano G, Domchek SM, Evans DG, Fischerova D, Harbeck N, Kuhl C, Lemley B, Levy-Lahad E, Lambertini M, Ledermann JA, Loibl S, Phillips KA, Paluch-Shimon S; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org.
Ann Oncol. 2023 Jan;34(1):33-47. doi: 10.1016/j.annonc.2022.10.004. Epub 2022 Oct 25.
Hereditary Ovarian Carcinoma: Cancer Pathogenesis Looking beyond BRCA1 and BRCA2.
Samuel D, Diaz-Barbe A, Pinto A, Schlumbrecht M, George S.
Cells. 2022 Feb 4;11(3):539. doi: 10.3390/cells11030539.
Hereditary Breast and Ovarian Cancer: An Updated Primer for OB/GYNs.
Bellcross CA.
Obstet Gynecol Clin North Am. 2022 Mar;49(1):117-147. doi: 10.1016/j.ogc.2021.11.005.
Multigene panel testing for hereditary breast and ovarian cancer in the province of Ontario.
Lerner-Ellis J, Mighton C, Lazaro C, Watkins N, Di Gioacchino V, Wong A, Chang MC, Charames GS.
J Cancer Res Clin Oncol. 2021 Mar;147(3):871-879. doi: 10.1007/s00432-020-03377-6. Epub 2020 Sep 3.
Hereditary ovarian cancer.
Prat J, Ribé A, Gallardo A.
Hum Pathol. 2005 Aug;36(8):861-70. doi: 10.1016/j.humpath.2005.06.006.
BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: Looking for the hidden meaning.
Fanale D, Pivetti A, Cancelliere D, Spera A, Bono M, Fiorino A, Pedone E, Barraco N, Brando C, Perez A, Guarneri MF, Russo TDB, Vieni S, Guarneri G, Russo A, Bazan V.
Crit Rev Oncol Hematol. 2022 Apr;172:103626. doi: 10.1016/j.critrevonc.2022.103626. Epub 2022 Feb 10.
Hereditary breast/ovarian cancer syndrome: a primer for obstetricians/gynecologists.
Meaney-Delman D, Bellcross CA.
Obstet Gynecol Clin North Am. 2013 Sep;40(3):475-512. doi: 10.1016/j.ogc.2013.05.009. Epub 2013 Jul 30.
Germline pathogenic variants identified in women with ovarian tumors.
Carter NJ, Marshall ML, Susswein LR, Zorn KK, Hiraki S, Arvai KJ, Torene RI, McGill AK, Yackowski L, Murphy PD, Xu Z, Solomon BD, Klein RT, Hruska KS.
Gynecol Oncol. 2018 Dec;151(3):481-488. doi: 10.1016/j.ygyno.2018.09.030. Epub 2018 Oct 12.
Hereditary Ovarian Cancer and Risk Reduction.
Andrews L, Mutch DG.
Best Pract Res Clin Obstet Gynaecol. 2017 May;41:31-48. doi: 10.1016/j.bpobgyn.2016.10.017. Epub 2017 Jan 17.
